Indications
* Gastroesophageal reflux disease (GERD):
– treatment of erosive reflux esophagitis;
–long-term maintenance treatment after healing of erosive reflux esophagitis to prevent relapse;
–symptomatic treatment of GERD.
· Peptic ulcer of the stomach and duodenum.
As part of combination therapy:
– treatment of duodenal ulcers associated with Helicobacter pylori;
– prevention of relapses of peptic ulcers associated with Helicobacter pylori
· * Long-term acid-suppressing therapy in patients who have suffered bleeding from peptic ulcers (after intravenous use of drugs that reduce the secretion of gastric glands, to prevent relapse).
* Patients taking long-term nonsteroidal anti-inflammatory drugs (NSAIDs):
– healing of stomach ulcers associated with NSAID use;
– prevention of gastric and duodenal ulcers associated with NSAID use in patients at risk.
* Zollinger-Ellison syndrome and other conditions characterized by abnormal hypersecretion of the gastric glands, including idiopathic hypersecretion.
Reviews
There are no reviews yet